LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 145 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $5,000 | +25.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $4,000 | -20.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $5,000 | -50.0% | 500 | -37.5% | 0.00% | -66.7% |
| Q3 2017 | $10,000 | -23.1% | 800 | 0.0% | 0.00% | -25.0% |
| Q2 2017 | $13,000 | +18.2% | 800 | 0.0% | 0.00% | +33.3% |
| Q1 2017 | $11,000 | 0.0% | 800 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $11,000 | -21.4% | 800 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $14,000 | 0.0% | 800 | -17.9% | 0.00% | -20.0% |
| Q2 2016 | $14,000 | +250.0% | 975 | +225.0% | 0.01% | +150.0% |
| Q1 2016 | $4,000 | +33.3% | 300 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $3,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $62,009,000 | 100.00% |
| Artal Group S.A. | 57,517,977 | $825,383,000 | 17.04% |
| NEA Management Company, LLC | 2,382,286 | $34,186,000 | 1.77% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $512,000 | 1.49% |
| BRIDGER MANAGEMENT, LLC | 1,029,926 | $14,779,000 | 0.95% |
| FALCON POINT CAPITAL, LLC | 287,809 | $4,130,000 | 0.71% |
| HANCOCK WHITNEY CORP | 664,025 | $9,529,000 | 0.40% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 494,380 | $7,094,000 | 0.39% |
| ELLINGTON MANAGEMENT GROUP LLC | 11,700 | $168,000 | 0.23% |
| Convergence Investment Partners, LLC | 114,157 | $1,638,000 | 0.22% |